Literature DB >> 18504405

A contraction assay system using established human bronchial smooth muscle cells.

Noriko Kitamura1, Osamu Kaminuma, Noriaki Kobayashi, Akio Mori.   

Abstract

BACKGROUND: To further understand the mechanisms of airway obstruction in asthma, it is crucial to investigate contractile responses of human airway smooth muscle. An in vitro assay system employing collagen gels embedded with well-established bronchial smooth muscle cells of human origin was explored in the present study.
METHODS: Commercially available cultured human bronchial smooth muscle cells were embedded into a collagen gel. Well-known constrictors, histamine and methacholine, were added to the gel. The gel images were captured by an image analyzer, and contractile responses were evaluated.
RESULTS: Histamine and methacholine induced contraction of the gels in a dose-dependent manner. Pyrilamine, an H1 receptor antagonist, inhibited gel contraction in an agonist-specific manner.
CONCLUSION: Our contraction assay system, employing widely distributed cultured cells, was highly reproducible and precise. It may go a long way toward understanding mechanisms of asthmatic responses and evaluation of antiasthma drugs. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18504405     DOI: 10.1159/000126059

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  2 in total

1.  Development of vascular smooth muscle contractility by endothelium-derived transforming growth factor β proteins.

Authors:  Chiwaka Kimura; Shuhei Konishi; Maki Hasegawa; Masahiro Oike
Journal:  Pflugers Arch       Date:  2013-07-26       Impact factor: 3.657

2.  Role of miR-185-5p as modulator of periostin synthesis and smooth muscle contraction in asthma.

Authors:  José M Rodrigo-Muñoz; José A Cañas; Beatriz Sastre; Marta Gil-Martínez; Raquel García Latorre; Joaquín Sastre; Victoria Del Pozo
Journal:  J Cell Physiol       Date:  2021-10-26       Impact factor: 6.513

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.